HIV HGM BIOBANK, Spain

Registration Status: Pending

Objective: Focused widely in infetious disease and particularly in HIV infection since its creation in 2004. In 2008 HIV HGM BioBank expanded it purpose and collections to many other fields as metabolics or respiratory illnesses, oncology, rare diseases, etc. We manage private and open collections, as well as participate in clinical trials and services as ELISAS, DNA extraction, mass cytometry...

Registered Biobank Name	HIV HGM BIOBANK
Biobank Leader	Irene Consuegra FernÃ¡ndez
Country	Spain
Email for biobank inquiries	biobancovih.hgugm@gmail.com
Principal Investigator	PHD.MD. MARIA DE LOS ANGELES MUÃ‘OZ FERNANDEZ
Website	www.hivhgmbiobank.com
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).